Maronde R F, Milgrom M, Vlachakis N D, Chan L
JAMA. 1983 Jan 14;249(2):237-41.
The effects of amiloride hydrochloride on thiazide-induced hypokalemia were evaluated. In metabolic balance studies, amiloride reversed thiazide-induced urinary potassium loss, restored plasma bicarbonate concentration and pH to pretreatment levels, and produced further increases in aldosterone secretion. Effects of long-term administration of hydrochlorothiazide and an amiloride-hydrochlorothiazide combination were compared in outpatients who had experienced thiazide-induced hypokalemia while receiving oral potassium supplements. After eight weeks, those given hydrochlorothiazide alone had an average serum potassium level of 3.01 +/- 0.08 mEq/L). Those given the amiloride-hydrochlorothiazide combination had an average serum potassium level of 3.75 +/- 0.008 mEq/L, not significantly different from the control value (3.82 +/- 0.08 mEq/L). Both groups had increased plasma aldosterone concentrations and plasma renin activity. The potassium-conserving effect of amiloride persisted with extended therapy.
评估了盐酸阿米洛利对噻嗪类药物所致低钾血症的影响。在代谢平衡研究中,阿米洛利可逆转噻嗪类药物所致的尿钾丢失,使血浆碳酸氢盐浓度和pH恢复至治疗前水平,并使醛固酮分泌进一步增加。在接受口服钾补充剂时曾发生噻嗪类药物所致低钾血症的门诊患者中,比较了长期服用氢氯噻嗪和氢氯噻嗪 - 阿米洛利联合用药的效果。八周后,单独服用氢氯噻嗪的患者血清钾平均水平为3.01±0.08 mEq/L)。服用氢氯噻嗪 - 阿米洛利联合用药的患者血清钾平均水平为3.75±0.008 mEq/L,与对照值(3.82±0.08 mEq/L)无显著差异。两组患者的血浆醛固酮浓度和血浆肾素活性均升高。阿米洛利的保钾作用在延长治疗期间持续存在。